Sandrine Richard

TL;DR: Preclinical and clinical data on pertuzumab are synthetised and the mechanisms underlying the synergistic activity of the combination pertuzuumab-trastuzuab which are essentially due to their complementary mode of action are highlighted.

TL;DR: After PSM for known prognostic factors, the prognosis of BCP patients did not differ from that of young patients with non-BCP, and no difference in recurrence type was observed between the groups.

TL;DR: Among the new anti-HER2 agents, second-generation tyrosine kinase inhibitors and bifunctional antibodies are promising approaches that will help to improve disease control and curability of HER2-positive breast cancers.

TL;DR: This case of splenic metastasis from carcinoma of the breast occurring 5 years after initial treatment is the first reported case with use of an in vivo demonstration of estrogen receptors expression in the spleen metastasis using PET/CT with 16α-[18F]-Fluoroestradiol.

TL;DR: MGT guaranteed care continuity in BC/OC patients during the critical phases of the COVID-19 pandemic, with immediate implications for PV carriers and for the first time the successful implementation of MGT in France.